Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Sony (SONY) Increases Despite Market Slip: Here's What You Need to Know
Sony (SONY) Increases Despite Market Slip: Here's What You Need to Know

Sony (SONY) closed at $24.70 in the latest trading session, marking a +1.02% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.07%.

The electronics and

Nice (NICE) Increases Despite Market Slip: Here's What You Need to KnowPhoto, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Nice (NICE) Increases Despite Market Slip: Here's What You Need to Know

Nice (NICE) closed at $164.42 in the latest trading session, marking a +0.4% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.07%.

The software

Bit Digital, Inc. (BTBT) Flat As Market Sinks: What You Should Know
Bit Digital, Inc. (BTBT) Flat As Market Sinks: What You Should Know

In the latest market close, Bit Digital, Inc. (BTBT) reached $2.08, with no movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.07%.

Shares of the

Why the Market Dipped But Micron (MU) Gained Today
Why the Market Dipped But Micron (MU) Gained Today

In the latest market close, Micron (MU) reached $85.86, with a +0.83% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.07%.

The chipmaker's stock

Why the Market Dipped But Workday (WDAY) Gained Today
Why the Market Dipped But Workday (WDAY) Gained Today

In the latest trading session, Workday (WDAY) closed at $259.18, marking a +0.47% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.07%.

Prior to today's

Ispire Technology Inc. (ISPR) Reports Q3 Loss, Lags Revenue Estimates
Ispire Technology Inc. (ISPR) Reports Q3 Loss, Lags Revenue Estimates

Ispire Technology Inc. (ISPR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.11 per share a year ago. These

SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates
SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates

SpringWorks Therapeutics (SWTX) came out with a quarterly loss of $1.11 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to loss of $1.18 per share a year ago. These

Monster Beverage (MNST) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesPhoto, wide shot, wide-angle lens,  Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png
Monster Beverage (MNST) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Monster Beverage (MNST) reported $1.85 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.4%. EPS of $0.47 for the same period compares to $0.42 a year

Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton
Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton

Friday, May 9, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney

AI Stocks Are Back (MSFT, NVDA, PLTR)Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
AI Stocks Are Back (MSFT, NVDA, PLTR)

After weeks of market turbulence driven by tariff headlines, investor focus is shifting back to one of the strongest secular growth stories of this cycle: artificial intelligence. With geopolitical

Brian's Big Idea: Small Cap Growth in Tech Stock
Brian's Big Idea: Small Cap Growth in Tech Stock

Brian Bolan is the aggressive growth stock strategist at Zacks Investment Research and his big idea this week is small cap tech stocks . We are into the earnings season and normally that would drive

Should You Buy, Hold, or Sell RGTI Stock Before Q1 Earnings?
Should You Buy, Hold, or Sell RGTI Stock Before Q1 Earnings?

Rigetti Computing RGTI is set to report first-quarter 2025 results on May 12.The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $2.46 million, indicating a decline of

Top 4 GARP Stocks With Attractive PEG Ratios to Watch
Top 4 GARP Stocks With Attractive PEG Ratios to Watch

In the equity market, investments need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that arises often is whether one should resort to a

Should Heritage Insurance Stock Be in Your Portfolio Post Q1 Earnings?Photo, wide shot, wide-angle lens, soft focus,  Underwriting company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-N0Y6W7kvQQgUHnb7hSHO9TTV.png?st=2024-05-14T11%3A36%3A30Z&se=2024-05-14T13%3A36%3A30Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2024-05-13T19%3A10%3A46Z&ske=2024-05-14T19%3A10%3A46Z&sks=b&skv=2021-08-06&sig=1qvKLOloU0OWrpqzcuH7YcgBv7QI0hAOq2gAtJGiGqs%3D
Should Heritage Insurance Stock Be in Your Portfolio Post Q1 Earnings?

Heritage Insurance Holdings, Inc. HRTG reported mixed first-quarter 2025 results, wherein the bottom line beat the Zacks Consensus Estimate but the top line missed the same. Net premiums earned

Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2025, Evolent Health (EVH) reported revenue of $483.65 million, down 24.4% over the same period last year. EPS came in at $0.06, compared to $0.34 in the year-ago

Compared to Estimates, Oportun Financial (OPRT) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, Oportun Financial (OPRT) Q1 Earnings: A Look at Key Metrics

Oportun Financial Corporation (OPRT) reported $235.9 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 5.8%. EPS of $0.40 for the same period compares to

Monster Beverage Q1 Earnings Beat, Lower Sales Across Segments HurtPhoto, wide shot, wide-angle lens,  Laundry service, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/7d06f1e2-46d1-4cac-90e0-6cc2313e43fe.png
Monster Beverage Q1 Earnings Beat, Lower Sales Across Segments Hurt

Monster Beverage Corporation MNST delivered mixed first-quarter 2025 results, wherein the bottom line beat the Zacks Consensus Estimate while the top line missed. Earnings increased year over year

Vistra Q1 Earnings In Line With Estimates, Revenues Rise Y/Y
Vistra Q1 Earnings In Line With Estimates, Revenues Rise Y/Y

Vistra VST reported first-quarter 2025 earnings of 46 cents per share, in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported earnings of 23 cents per share. (See

Kymera' s Q1 Loss Narrower Than Expected, Pipeline Progress Encouraging
Kymera' s Q1 Loss Narrower Than Expected, Pipeline Progress Encouraging

Kymera Therapeutics, Inc. KYMR reported a first-quarter 2025 loss of 82 cents per share, narrower than the Zacks Consensus Estimate of a loss of 92 cents. In the year-ago quarter, Kymera reported a

Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up

Veracyte, Inc. VCYT delivered first-quarter 2025 earnings of 31 cents per share, which marked a stupendous improvement of 63.2% from the year-ago period’s figure of 19 cents. The bottom line beat

Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025
Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025

Prothena Corporation PRTA reported first-quarter 2025 loss per share of $1.12, much wider than the Zacks Consensus Estimate of a loss of 92 cents.  In the year-ago quarter, the company posted a loss

AI Stocks Retreat, but the AI Revolution is Firmly IntactPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
AI Stocks Retreat, but the AI Revolution is Firmly Intact

AI Growth is Still in the Early Innings…According to a report by Bloomberg Intelligence, “The generative AI market is poised to explode, growing to $1.3 trillion over the next 10 years from a market

NWSA Misses Q3 Earnings Estimates, Shares Up on Strong Top-Line Growth
NWSA Misses Q3 Earnings Estimates, Shares Up on Strong Top-Line Growth

News Corporation NWSA reported third-quarter fiscal 2025 earnings of 17 cents per share, which missed the Zacks Consensus Estimate by 10.53% but increased 54.5% year over year.Find the latest EPS

Affirm's Q3 Earnings Beat Estimates on Solid GMV Growth
Affirm's Q3 Earnings Beat Estimates on Solid GMV Growth

Affirm Holdings, Inc. AFRM reported fiscal third-quarter 2025 earnings of a penny against the Zacks Consensus Estimate of a loss of nine cents per share and the prior-year quarter’s loss of 43 cents

OUTFRONT Media Q1 AFFO & Revenues Miss, Interest Expenses Dip
OUTFRONT Media Q1 AFFO & Revenues Miss, Interest Expenses Dip

OUTFRONT Media Inc. OUT reported first-quarter 2025 adjusted funds from operations (AFFO) per share of 14 cents, missing the Zacks Consensus Estimate of 15 cents. The reported figure remained